![Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA® Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®](http://photos.newswire.ca/images/20151215_C6454_PHOTO_EN_564829.jpg)
Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr) Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®
![KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy](https://c8.alamy.com/comp/2C6A97H/kyiv-ukraine-may-28-2020-gastroenterology-generic-drug-omeprazole-by-teva-box-and-blisters-closeup-on-white-teva-pharmaceuticals-is-an-american-2C6A97H.jpg)
KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy
![Teva Pharmaceuticals | Latest & Breaking News on Teva Pharmaceuticals | Photos, Videos, Breaking Stories and Articles on Teva Pharmaceuticals Teva Pharmaceuticals | Latest & Breaking News on Teva Pharmaceuticals | Photos, Videos, Breaking Stories and Articles on Teva Pharmaceuticals](https://images.moneycontrol.com/static-mcnews/2018/06/USFDAFDAPILLSDRUGSTABLETSPHARMA-770x433.jpg?impolicy=website&width=400&height=225)
Teva Pharmaceuticals | Latest & Breaking News on Teva Pharmaceuticals | Photos, Videos, Breaking Stories and Articles on Teva Pharmaceuticals
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg?download=1)